HK1019704A1 - Process for manufacturing ophthalmic suspensions containing brinzolamide - Google Patents
Process for manufacturing ophthalmic suspensions containing brinzolamideInfo
- Publication number
- HK1019704A1 HK1019704A1 HK99104734A HK99104734A HK1019704A1 HK 1019704 A1 HK1019704 A1 HK 1019704A1 HK 99104734 A HK99104734 A HK 99104734A HK 99104734 A HK99104734 A HK 99104734A HK 1019704 A1 HK1019704 A1 HK 1019704A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- suspensions containing
- ophthalmic suspensions
- brinzolamide
- manufacturing ophthalmic
- containing brinzolamide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A61K31/77—Polymers containing oxygen of oxiranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3282096P | 1996-12-11 | 1996-12-11 | |
US08/886,933 US6071904A (en) | 1996-12-11 | 1997-07-02 | Process for manufacturing ophthalmic suspensions |
PCT/US1997/015727 WO1998025620A1 (en) | 1996-12-11 | 1997-09-05 | Process for manufacturing ophthalmic suspensions |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1019704A1 true HK1019704A1 (en) | 2000-02-25 |
Family
ID=26708929
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK99104734A HK1019704A1 (en) | 1996-12-11 | 1999-10-23 | Process for manufacturing ophthalmic suspensions containing brinzolamide |
Country Status (14)
Country | Link |
---|---|
US (1) | US6071904A (es) |
EP (1) | EP0941094B1 (es) |
JP (1) | JP3611863B2 (es) |
AT (1) | ATE209917T1 (es) |
CA (1) | CA2274680C (es) |
DE (2) | DE69708912T2 (es) |
DK (1) | DK0941094T3 (es) |
ES (1) | ES2169416T3 (es) |
FR (1) | FR09C0022I2 (es) |
HK (1) | HK1019704A1 (es) |
LU (1) | LU91554I2 (es) |
NL (1) | NL300388I2 (es) |
PT (1) | PT941094E (es) |
WO (1) | WO1998025620A1 (es) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000001365A1 (en) * | 1998-06-30 | 2000-01-13 | Leo Pharmaceutical Products Ltd. A/S (Løvens Kemiske Fabrik Produktionsaktieselskab) | Prolonged release ophthalmic compositions containing a fluoroquinolone |
US20030008853A1 (en) * | 2001-05-21 | 2003-01-09 | Alcon, Inc. | Method for treating dry eye disorders |
US7112588B2 (en) * | 2001-05-21 | 2006-09-26 | Alcon, Inc. | Use of proteasome inhibitors to treat dry eye disorders |
DE60213230T2 (de) | 2001-05-21 | 2006-11-23 | Alcon Inc. | Verwendung von NF-Kappa.B Inhibitoren zur Behandlung von Augentrockenheit |
US6872382B1 (en) | 2001-05-21 | 2005-03-29 | Alcon, Inc. | Use of selective PDE IV inhibitors to treat dry eye disorders |
AU2002308760B2 (en) | 2001-05-21 | 2006-05-11 | Alcon, Inc. | Use of proteasome inhibitors to treat dry eye disorders |
TWI298257B (en) | 2001-05-31 | 2008-07-01 | Allergan Inc | Hypotensive lipid and timolol compositions and methods of using same |
US6645994B1 (en) | 2001-06-01 | 2003-11-11 | Alcon, Inc. | Method of treating dry eye disorders |
EP1480636B1 (en) * | 2002-03-01 | 2007-04-18 | Novagali Pharma SA | Self emulsifying drug delivery systems for taxoids |
ES2301964T3 (es) | 2003-01-21 | 2008-07-01 | Senju Pharmaceutical Co., Ltd. | Preparado liquido acuoso que contiene acido 2-amino-3-(4-bromobenzoil)fenilacetico. |
DE602005026225D1 (de) * | 2004-03-12 | 2011-03-24 | Cipla Ltd | Sterilisationsprozess für Steroide |
PL1891939T3 (pl) * | 2006-07-28 | 2014-01-31 | Santen Sas | Kompozycje zawierające czwartorzędowe związki amonowe |
WO2008035246A2 (en) | 2006-07-28 | 2008-03-27 | Novagali Pharma Sa | Compositions containing quaternary ammonium compounds |
TWI544927B (zh) | 2008-03-17 | 2016-08-11 | 愛爾康研究有限公司 | 具有低濃度的表面活性劑以促進治療劑之生物可利用性的藥學組成物 |
TWI489997B (zh) * | 2009-06-19 | 2015-07-01 | Alcon Res Ltd | 含有硼酸-多元醇錯合物之水性藥學組成物 |
MX2012006401A (es) * | 2009-12-03 | 2012-07-10 | Lupin Ltd | Proceso para preparar composiciones oftalmicas farmaceuticas. |
EP2394637A1 (en) * | 2010-05-21 | 2011-12-14 | Zaklady Farmaceutyczne Polpharma SA | Process for obtaining sterile brinzolamide suspensions |
US9061034B2 (en) | 2010-07-29 | 2015-06-23 | Allergan, Inc. | Preservative free bimatoprost and timolol solutions |
CA2807081C (en) | 2010-07-29 | 2018-09-18 | Allergan, Inc. | Preservative free bimatoprost and timolol solutions |
WO2012053011A2 (en) | 2010-10-18 | 2012-04-26 | Usv Limited | Ophthalmic compositions comprising brinzolamide |
WO2013025696A1 (en) | 2011-08-15 | 2013-02-21 | Teva Pharmaceutical Industries Ltd. | Ophthalmic formulations and processes for their preparation |
EP2638909A1 (en) | 2012-03-15 | 2013-09-18 | Azad Pharmaceutical Ingredients AG | Process for preparing sterile Brinzolamide |
GR1007906B (el) * | 2012-03-22 | 2013-05-30 | Φαρματεν Αβεε, | Οφθαλμικο φαρμακευτικο σκευασμα περιεχον ενα αναστολεα καρβονικης ανυδρασης και μεθοδος για την παρασκευη αυτου |
ES2624250T3 (es) | 2012-05-09 | 2017-07-13 | Icrom Spa | Producción de brinzolamida farmacéutica estéril |
US20150119386A1 (en) * | 2012-05-21 | 2015-04-30 | Aurobindo Pharma Limited | Process for preparing opthalmic suspension of brinzolamide |
US9649319B2 (en) | 2012-10-11 | 2017-05-16 | Indoco Remedies Limited | Process for manufacturing sterile brinzolamide ophthalmic suspension |
CN104721136A (zh) * | 2013-02-21 | 2015-06-24 | 四川大学 | 一种布佐林胺眼用纳米混悬剂及其制备方法 |
US9801813B2 (en) * | 2013-10-17 | 2017-10-31 | Sentiss Pharma Private Limited | Preservative-free ophthalmic pharmaceutical formulation |
US9820991B2 (en) * | 2013-11-08 | 2017-11-21 | Sentiss Pharma Private Limited | Pharmaceutical composition comprising brinzolamide |
WO2015068105A1 (en) | 2013-11-08 | 2015-05-14 | Sentiss Pharma Private Limited | An improved process for manufacturing sterile ophthalmic pharmaceutical suspensions |
ES2838756T3 (es) | 2014-01-24 | 2021-07-02 | Sentiss Pharma Private Ltd | Composición farmacéutica que comprende brinzolamida |
PL407710A1 (pl) * | 2014-03-28 | 2015-10-12 | Instytut Farmaceutyczny | Sposób wytwarzania preparatu kropli do oczu w postaci zawiesiny zawierającej brynzolamid i preparat wytworzony tym sposobem |
JP6279395B2 (ja) * | 2014-05-01 | 2018-02-14 | 東亜薬品株式会社 | ブリンゾラミド懸濁性点眼液組成物の製造方法 |
ES2954412T3 (es) | 2014-10-20 | 2023-11-22 | Sentiss Pharma Private Ltd | Solución oftálmica |
TWI700085B (zh) * | 2015-06-22 | 2020-08-01 | 新源生物科技股份有限公司 | 酪胺酸激酶抑制劑之眼用調配物的用途 |
CN107582519A (zh) * | 2017-06-01 | 2018-01-16 | 合肥远志医药科技开发有限公司 | 一种布林佐胺滴眼液制剂及其制备方法 |
GR1009419B (el) | 2017-11-07 | 2018-12-14 | Φαρματεν Αβεε | Οφθαλμικο φαρμακευτικο σκευασμα που περιεχει εναν συνδυασμο βρινζολαμιδης και βριμονιδινης και μεθοδος για την παρασκευη αυτου |
US11298360B2 (en) | 2018-04-25 | 2022-04-12 | Shilpa Medicare Limited | Ophthalmic compositions of brinzolamide |
GR1009616B (el) * | 2018-07-20 | 2019-10-11 | Φαρματεν Α.Β.Ε.Ε. | Οφθαλμικο φαρμακευτικο σκευασμα που περιεχει βρινζολαμιδη και τιμολολη και μεθοδος παρασκευης αυτου |
WO2020240451A1 (en) | 2019-05-29 | 2020-12-03 | Lupin Limited | In-situ gelling nanoemulsion of brinzolamide |
US20220105101A1 (en) * | 2020-10-05 | 2022-04-07 | Somerset Therapeutics, Llc | Efficient brinzolamide and brimonidine compositions |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5378703A (en) * | 1990-04-09 | 1995-01-03 | Alcon Laboratories, Inc. | Sulfonamides useful as carbonic anhydrase inhibitors |
RO113612B1 (ro) * | 1991-04-17 | 1998-09-30 | Merck & Co Inc | Compozitie oftalmica |
DK0625903T3 (da) * | 1992-02-21 | 1999-05-10 | Alcon Lab Inc | Topiske antiglaukompræparater omfattende carbonsyreanhydraseinhibitorer og beta-blokkere |
US5362758A (en) * | 1992-09-18 | 1994-11-08 | Pfizer Inc. | Ophthalmic piroxicam solution |
US5346702A (en) * | 1992-12-04 | 1994-09-13 | Sterling Winthrop Inc. | Use of non-ionic cloud point modifiers to minimize nanoparticle aggregation during sterilization |
US5429824A (en) * | 1992-12-15 | 1995-07-04 | Eastman Kodak Company | Use of tyloxapole as a nanoparticle stabilizer and dispersant |
US5576016A (en) * | 1993-05-18 | 1996-11-19 | Pharmos Corporation | Solid fat nanoemulsions as drug delivery vehicles |
US5422116A (en) * | 1994-02-18 | 1995-06-06 | Ciba-Geigy Corporation | Liquid ophthalmic sustained release delivery system |
-
1997
- 1997-07-02 US US08/886,933 patent/US6071904A/en not_active Expired - Lifetime
- 1997-09-05 PT PT97939835T patent/PT941094E/pt unknown
- 1997-09-05 AT AT97939835T patent/ATE209917T1/de active
- 1997-09-05 ES ES97939835T patent/ES2169416T3/es not_active Expired - Lifetime
- 1997-09-05 DK DK97939835T patent/DK0941094T3/da active
- 1997-09-05 CA CA002274680A patent/CA2274680C/en not_active Expired - Lifetime
- 1997-09-05 DE DE69708912T patent/DE69708912T2/de not_active Expired - Lifetime
- 1997-09-05 WO PCT/US1997/015727 patent/WO1998025620A1/en active IP Right Grant
- 1997-09-05 DE DE122009000016C patent/DE122009000016I1/de active Pending
- 1997-09-05 EP EP97939835A patent/EP0941094B1/en not_active Expired - Lifetime
- 1997-09-05 JP JP52598698A patent/JP3611863B2/ja not_active Expired - Lifetime
-
1999
- 1999-10-23 HK HK99104734A patent/HK1019704A1/xx not_active IP Right Cessation
-
2009
- 2009-04-22 LU LU91554C patent/LU91554I2/fr unknown
- 2009-05-11 NL NL300388C patent/NL300388I2/nl unknown
- 2009-05-25 FR FR09C0022C patent/FR09C0022I2/fr active Active
Also Published As
Publication number | Publication date |
---|---|
EP0941094A1 (en) | 1999-09-15 |
DE69708912D1 (de) | 2002-01-17 |
DE122009000016I1 (de) | 2009-06-25 |
AU718079B2 (en) | 2000-04-06 |
CA2274680A1 (en) | 1998-06-18 |
CA2274680C (en) | 2003-11-18 |
NL300388I2 (nl) | 2010-02-01 |
US6071904A (en) | 2000-06-06 |
AU4183897A (en) | 1998-07-03 |
EP0941094B1 (en) | 2001-12-05 |
LU91554I2 (fr) | 2009-06-22 |
JP3611863B2 (ja) | 2005-01-19 |
ATE209917T1 (de) | 2001-12-15 |
DE69708912T2 (de) | 2002-04-11 |
FR09C0022I2 (es) | 2010-06-11 |
DK0941094T3 (da) | 2002-01-07 |
NL300388I1 (nl) | 2009-07-01 |
WO1998025620A1 (en) | 1998-06-18 |
PT941094E (pt) | 2002-05-31 |
JP2000501749A (ja) | 2000-02-15 |
FR09C0022I1 (es) | 2009-09-25 |
ES2169416T3 (es) | 2002-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1019704A1 (en) | Process for manufacturing ophthalmic suspensions containing brinzolamide | |
AU6075596A (en) | Cryptographic communication process | |
CA2265712A1 (en) | Intermediates and process for preparing olanzapine | |
ZA965233B (en) | TiO2 slurry process. | |
AU1624897A (en) | Intraocular lens and process for the production thereof | |
AU3626799A (en) | Novel polyisocyanate and process for producing the same | |
AU3727397A (en) | Elastomers, processes for their manufacture, and articles made from these elastomers | |
EP0667366A3 (en) | Process for the production of aromatic polycarbonates. | |
ZA989631B (en) | Process for the production of N-Butanol. | |
EP0908484A4 (en) | PROCESSES FOR PRODUCING POLYCARBONATE | |
HUT67611A (en) | Process for producing optical active 1-(4-nitrophenyl)-4-methyl-7,8-methylen dioxi-3,4-dihydro-2h-2,2-benzodiazepine | |
AU6669196A (en) | Novel sulfur compounds and process for producing the same | |
AU8467398A (en) | Fluorescent photosensitive glasses and process for the production thereof | |
AU6039394A (en) | Process for making 1,3-diols and 3-hydroxyaldehydes | |
HUP0002140A3 (en) | Process for the production of sulphonamides | |
AU4377697A (en) | Manufacturing process for 6-aminocapronitrile | |
EP0662644A3 (en) | Electrophotographic support and its manufacturing process. | |
AU648613B2 (en) | Electrode, and process for manufacturing it | |
EP0864597A4 (en) | METHOD FOR PRODUCING POLYCARBONATE | |
EP0658604A3 (de) | Verfahren zur Herstellung von metalfreien Phthalocyaninen. | |
EP0666245A3 (en) | Substrate and process for its manufacture. | |
AU9629098A (en) | Ophthalmic lens production process | |
ZA962851B (en) | Process for vulcanization. | |
EP0744276A3 (de) | Verfahren zur Herstellung eines integriert optischen Deckelbauteils, integriert optisches Deckelbauteil, Verfahren zur Herstellung eines integriert optischen Bauteils mit einem integriert optischen Deckelbauteil und integriert optisches Bauteil mit einem integriert optischen Deckelbauteil | |
AU8467498A (en) | Fluorescent photosensitive vitroceramics and process for the production thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PF | Patent in force | ||
PE | Patent expired |
Effective date: 20170904 |